Literature DB >> 3514474

[Ofloxacin versus pipemidic acid and co-trimoxazole].

R Wittenberger.   

Abstract

In a study comprising 116 patients at a hospital for general care, ofloxacin was tested in various doses and at various time intervals against pipemidic acid (for infections of the lower urinary tract) and co-trimoxazole forte (for infections of the upper urinary tract). Ofloxacin proved superior to the other drugs both clinically and, particularly, bacteriologically. Of 77 patients treated with ofloxacin, only one complained of diarrhoea as a side-effect of the drug.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514474     DOI: 10.1007/bf01645210

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  2 in total

1.  [Treatment of urinary tract infections with pipemidic acid and cotrimoxazol. A comparative study].

Authors:  J Schüller; V Walther; P Mayer; F J Marx
Journal:  MMW Munch Med Wochenschr       Date:  1983-05-20

2.  [Is resistance to antibiotics changing? Development of resistance of Enterobactericeae from specimens 1977-1980].

Authors:  W Cullmann; W Opferkuch; D Schäfer; M Stieglitz
Journal:  Fortschr Med       Date:  1982-02-18
  2 in total
  5 in total

Review 1.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

2.  [Clinical pharmacology of ofloxacin: a new chemotherapeutic agent belonging to the gyrase inhibitor group].

Authors:  M Verho; E E Dagrosa; V Malerczyk
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 3.  Quinolones for uncomplicated acute cystitis in women.

Authors:  V Rafalsky; I Andreeva; E Rjabkova
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 4.  Use of quinolones in treatment of prostatitis and lower urinary tract infections.

Authors:  V T Andriole
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

5.  Pharmacokinetics of ofloxacin in healthy subjects and patients with impaired renal function.

Authors:  D Höffler; P Koeppe
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.